Cited 42 times in
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김상운 | - |
dc.contributor.author | 김성훈 | - |
dc.contributor.author | 김영태 | - |
dc.contributor.author | 김재훈 | - |
dc.contributor.author | 남은지 | - |
dc.contributor.author | 이마리아 | - |
dc.contributor.author | 임가원 | - |
dc.date.accessioned | 2014-12-19T16:34:34Z | - |
dc.date.available | 2014-12-19T16:34:34Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/89789 | - |
dc.description.abstract | BACKGROUND: Cancer stem cells (CSCs) are thought to be a source of tumor recurrence due to their stem cell-like properties. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs, and dysregulation of miRNAs has an important role in tumorigenesis. Cluster of differentiation (CD) 133(+) and spheroid formation have been reported to be one of the main features of ovarian CSCs. Therefore, we determined the miRNA expression profile of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line. METHODS: Initially, we confirmed the enrichment of the OVCAR3 CD133 subpopulation by evaluating in vitro anchorage-independent growth. After obtaining a subpopulation of CD133(+) OVCAR3 cells with > 98% purity via cell sorting, miRNA microarray and real-time reverse transcription-polymerase chain reaction (RT-PCR) were performed to evaluate its miRNA profile. RESULTS: We found 37 differentially expressed miRNAs in the CD133(+) spheroid-forming subpopulation of OVCAR3 cells, 34 of which were significantly up-regulated, including miR-205, miR-146a, miR-200a, miR-200b, and miR-3, and 3 of which were significantly down-regulated, including miR-1202 and miR-1181. CONCLUSIONS: Our results indicate that dysregulation of miRNA may play a role in the stem cell-like properties of ovarian CSCs. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | BMC MEDICAL GENOMICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | AC133 Antigen | - |
dc.subject.MESH | Antigens, CD/metabolism* | - |
dc.subject.MESH | Blotting, Western | - |
dc.subject.MESH | Cell Proliferation/drug effects | - |
dc.subject.MESH | Cluster Analysis | - |
dc.subject.MESH | Drug Resistance, Neoplasm/drug effects | - |
dc.subject.MESH | Drug Resistance, Neoplasm/genetics | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Flow Cytometry | - |
dc.subject.MESH | Gene Expression Profiling | - |
dc.subject.MESH | Gene Expression Regulation, Neoplastic | - |
dc.subject.MESH | Glycoproteins/metabolism* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | MicroRNAs/genetics* | - |
dc.subject.MESH | MicroRNAs/metabolism | - |
dc.subject.MESH | Neoplastic Stem Cells/drug effects | - |
dc.subject.MESH | Neoplastic Stem Cells/metabolism | - |
dc.subject.MESH | Neoplastic Stem Cells/pathology | - |
dc.subject.MESH | Oligonucleotide Array Sequence Analysis | - |
dc.subject.MESH | Ovarian Neoplasms/genetics* | - |
dc.subject.MESH | Ovarian Neoplasms/pathology* | - |
dc.subject.MESH | Paclitaxel/pharmacology | - |
dc.subject.MESH | Peptides/metabolism* | - |
dc.subject.MESH | Reproducibility of Results | - |
dc.subject.MESH | Reverse Transcriptase Polymerase Chain Reaction | - |
dc.subject.MESH | Spheroids, Cellular/drug effects | - |
dc.subject.MESH | Spheroids, Cellular/metabolism* | - |
dc.subject.MESH | Spheroids, Cellular/pathology* | - |
dc.subject.MESH | Tumor Cells, Cultured | - |
dc.title | MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics & Gynecology (산부인과학) | - |
dc.contributor.googleauthor | Eun Ji Nam | - |
dc.contributor.googleauthor | Maria Lee | - |
dc.contributor.googleauthor | Ga Won Yim | - |
dc.contributor.googleauthor | Jae Hoon Kim | - |
dc.contributor.googleauthor | Sunghoon Kim | - |
dc.contributor.googleauthor | Sang Wun Kim | - |
dc.contributor.googleauthor | Young Tae Kim | - |
dc.identifier.doi | 10.1186/1755-8794-5-18 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00595 | - |
dc.contributor.localId | A00526 | - |
dc.contributor.localId | A00729 | - |
dc.contributor.localId | A00876 | - |
dc.contributor.localId | A01262 | - |
dc.contributor.localId | A02748 | - |
dc.contributor.localId | A03354 | - |
dc.relation.journalcode | J00362 | - |
dc.identifier.eissn | 1755-8794 | - |
dc.identifier.pmid | 22643117 | - |
dc.subject.keyword | MicroRNA | - |
dc.subject.keyword | Cancer stem cell | - |
dc.subject.keyword | Ovarian cancer | - |
dc.subject.keyword | CD133 | - |
dc.subject.keyword | OVCAR3 | - |
dc.subject.keyword | Chemoresistance | - |
dc.contributor.alternativeName | Kim, Sang Wun | - |
dc.contributor.alternativeName | Kim, Sung Hoon | - |
dc.contributor.alternativeName | Kim, Young Tae | - |
dc.contributor.alternativeName | Kim, Jae Hoon | - |
dc.contributor.alternativeName | Nam, Eun Ji | - |
dc.contributor.alternativeName | Lee, Maria | - |
dc.contributor.alternativeName | Yim, Ga Won | - |
dc.contributor.affiliatedAuthor | Kim, Sung Hoon | - |
dc.contributor.affiliatedAuthor | Kim, Sang Wun | - |
dc.contributor.affiliatedAuthor | Kim, Young Tae | - |
dc.contributor.affiliatedAuthor | Kim, Jae Hoon | - |
dc.contributor.affiliatedAuthor | Nam, Eun Ji | - |
dc.contributor.affiliatedAuthor | Lee, Maria | - |
dc.contributor.affiliatedAuthor | Yim, Ga Won | - |
dc.citation.volume | 5 | - |
dc.citation.startPage | 18 | - |
dc.identifier.bibliographicCitation | BMC MEDICAL GENOMICS, Vol.5 : 18, 2012 | - |
dc.identifier.rimsid | 31905 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.